The Japan Patent Office has officially granted a patent to Moroccan doctor Youssef El Azouzi for his groundbreaking intravascular blood filter, reported Hespress news outlet.
This certification marks the first time an internal white blood cell filter has been registered in Japan, a global powerhouse in medical technology. The device successfully met all international standards for novelty and industrial application, following a landmark validation by the World Intellectual Property Organization in late 2025.
In statements to Hespress, Dr. El Azouzi emphasized the strategic weight of this patent, noting that Japan is the world leader in extracorporeal blood filtration technologies.
He pointed out that Japanese giants like Asahi Kasei and Terumo currently manufacture nearly 50% of the world’s external white blood cell filters. This makes recognition from the Japanese government a significant validation of his work on a global stage.
The invention offers transformative potential for complex medical procedures like organ transplants. Dr.El Azouzi explained that the filter protects new organs, including future animal-to-human transplants, by diverting white blood cells to prevent inflammatory attacks. This function is critical for ensuring that the body’s immune system does not destroy the newly transplanted tissue.
Furthermore, the filter is set to revolutionize cancer treatment, specifically for solid tumors. In the rapidly growing CAR T-cell therapy market, the device acts as an internal “logistics center.” It guides modified immune cells directly to a specific organ, such as the liver or lungs. This solves a major challenge in oncology, allowing doctors to concentrate life-saving treatments exactly where they are needed.
Dr. El Azouzi, through his Moroccan company Airtomedica, expressed his pride in securing this historic patent. While he awaits further reports from the United States, China, and the European Union, the Japanese approval establishes the device as a cornerstone of future precision medicine. The breakthrough was further solidified by international experts who confirmed the device meets every standard for global innovation.